Frank Morich
At a glance: Frank Morich is Director at Perspective Therapeutics (CATX). Their latest SEC Form 4, filed Nov 17, 2026, reported a purchase of $14K. On file: 2 purchase lines ($29K) and 0 sale lines ($0).
Disclosed holdings: about $22K of CATX stock: 30,000 shares reported on their latest Form 4 (filed Nov 17, 2026), valued at the Nov 20, 2026 close of $0.75. This counts only CATX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Perspective Therapeutics, Inc. (CATX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Frank Morich's InsiderPrint
3 trades from SEC Form 4 filings, 2022 to 2026, drawn as one fingerprint.
Reading this print: Almost only buys, trading about once a year, typically $15K a trade; often buys after the stock has fallen 15% or more.
- Bump outward: a purchase (3)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- David ColpmanDirector · ELUT · 100% match
- Richard J. DalyDirector · AQST · 100% match
- Matthew FergusonCFO · ELUT · 99% match
- William B. MintzSvp, Chief Strategy Officer · CTEV · 98% match
- Kirsten CastilloDirector · ACVA · 98% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2022
From the SEC's insider data sets: each open-market buy by Frank Morich, matched to how the stock did over the next 90 days against the S&P 500.
0 of 1 buy beat the S&P 500 (0%), median -24.5% vs. the index. Small sample: treat with care. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| CUE | May 31, 2022 | -24.5% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 17SEC | CATXPerspective Therapeutics, Inc.First buyStake +100% | Buy | 15,00030,000 held (+100%) | $0.94 | $14K | -20.2% |
| Nov 16SEC | CATXPerspective Therapeutics, Inc.First buyNew position | Buy | 15,000new position | $1.00 | $15K | -25.1% |
- Buy
Director Frank Morich bought $14K of CATX at $0.94 — raises the stake by 100%.
- Buy
Director Frank Morich bought $15K of CATX at $1.00 — first open-market purchase in our records; opens a new position.
Follow Frank Morich
Get one email when Frank Morich files a new purchase or sale. Free.
At most one email a day about Frank Morich, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.